Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 137 institutions that hold shares in the stock, with a total of 36.2 Million shares, which have been reported (via 13F filing form) to have a value of $342 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,834,794
shares
|
$36.3 Million
0.67% of portfolio
|
Q4 2024
Added 1.25%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,928,086
shares
|
$27.7 Million
0.06% of portfolio
|
Q4 2024
Reduced 21.62%
|
|
|
Menora Mivtachim Holdings Ltd.
|
Feb 13, 2025 Q4 2024 |
2,303,031
shares
|
$21.8 Million
0.15% of portfolio
|
Q3 2023
Reduced 8.96%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,193,950
shares
|
$20.8 Million
0.0% of portfolio
|
Q2 2024
Added 27.79%
|
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Feb 19, 2025 Q4 2024 |
1,749,142
shares
|
$16.5 Million
0.03% of portfolio
|
Q4 2024
New holding
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,630,000
shares
|
$15.4 Million
1.03% of portfolio
|
Q4 2024
Added 307.5%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,516,303
shares
|
$14.3 Million
8.73% of portfolio
|
Q4 2024
New holding
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,377,156
shares
|
$13 Million
0.0% of portfolio
|
Q4 2024
Added 2.69%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Feb 14, 2025 Q4 2024 |
1,371,638
shares
|
$13 Million
0.73% of portfolio
|
Q4 2024
New holding
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,200,000
shares
|
$11.4 Million
0.02% of portfolio
|
Q4 2023
Added 13.21%
|
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
1,120,473
shares
|
$10.6 Million
2.87% of portfolio
|
Q4 2024
Added 24.34%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 27, 2025 Q4 2024 |
965,929
shares
|
$9.14 Million
0.06% of portfolio
|
Q4 2024
Added 0.1%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
922,698
shares
|
$8.73 Million
0.0% of portfolio
|
Q4 2024
Added 1915.72%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
808,053
shares
|
$7.64 Million
0.0% of portfolio
|
Q4 2024
Added 5.0%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
767,300
shares
|
$7.26 Million
0.0% of portfolio
|
Q4 2024
Reduced 64.83%
|
|
|
Migdal Insurance & Financial Holdings Ltd.
|
Jan 28, 2025 Q4 2024 |
686,472
shares
|
$6.49 Million
0.1% of portfolio
|
Q1 2024
Added 5.89%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
645,785
shares
|
$6.11 Million
0.0% of portfolio
|
Q4 2024
Reduced 56.92%
|
|
|
Wildcat Capital Management, LLC
|
Jan 29, 2025 Q4 2024 |
495,606
shares
|
$4.69 Million
2.09% of portfolio
|
Q2 2023
New holding
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
492,515
shares
|
$4.66 Million
1.43% of portfolio
|
Q4 2024
Added 7.32%
|
|
|
Harel Insurance Investments & Financial Services Ltd.
|
Jan 21, 2025 Q4 2024 |
463,267
shares
|
$4.38 Million
0.08% of portfolio
|
Q3 2024
Reduced 0.06%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
461,902
shares
|
$4.37 Million
0.0% of portfolio
|
Q4 2024
Added 1.37%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
393,984
shares
|
$3.73 Million
0.0% of portfolio
|
Q4 2024
Added 2968.65%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
369,861
shares
|
$3.5 Million
0.57% of portfolio
|
Q4 2024
Added 6.42%
|
|
|
Cantor Fitzgerald, L. P.
New York, NY |
Feb 14, 2025 Q4 2024 |
360,000
shares
|
$3.41 Million
0.15% of portfolio
|
Q4 2024
New holding
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Feb 13, 2025 Q4 2024 |
324,324
shares
|
$3.07 Million
2.79% of portfolio
|
Q4 2024
Added 15.69%
|